Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma
Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma
- Bedikian, Agop Y., Millward, Michael, Kirkwood, John M., Haluska, Frank G., Pehamberger, Hubert, Conry, Robert, Gore, Martin, Trefzer, Uwe, Pavlick, Anna C., DeConti, Ronald, Hersh, Evan M., Hersey, Peter
Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin
Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma
Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress
2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2
Are you sure you would like to clear your session, including search history and login status?